Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHE | capital stock | Sale | -$978K | -2K | -8.08% | $489.13 | 22.8K | Nov 2, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHE | stock option(right to buy with tandem tax withholding) | Award | $5.39M | +12.1K | +40.31% | $445.35 | 42.1K | Oct 29, 2021 | capital stock | 12.1K | $445.35 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.67 to $492.75. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. |
F2 | Vesting in three equal annual installments commencing 10/28/2022. |